Search

everythinglearnresearchcommunity

for

Search:↓

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Using PGPR as biofertilizers can improve soil health and plant growth while reducing reliance on synthetic fertilizers.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

UV radiation and visible light can damage hair, but there are ways to protect it.

The conclusion is that a new method to measure hair shine was confirmed to match people's visual assessments.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Different hair types from various ethnic groups affect hair shine due to characteristics like thickness and shape.

Cetuximab can cause excessive eyelash growth.

The document concludes that certain chemicals can help maintain stem cell pluripotency and that understanding cell states is crucial for tissue regeneration.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Finasteride's effectiveness for frontal fibrosing alopecia is uncertain.

More research needed to confirm finasteride as standard treatment for FFA.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Glycogen metabolism is important for energy and processes in human hair follicles, and hair follicles may produce glucose from lactate.

Hair follicle stem cells can change their role to ensure proper hair development.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Researchers created a system that accurately aligns laser beams automatically.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.